ARTIFICIAL intelligence has discovered a new life-changing drug and human trials are already underway.

The biotech company behind the breakthrough has dosed its first patient with an AI-developed treatment for ALS patients.

Alice Zhang, 33, is the founder of Verge Genomics and a former neuroscience doctoral student at University of California.